Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bea75171dde1a806d6551e3f85787b64e> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bea75171dde1a806d6551e3f85787b64e NCIT_P378 "NCI" @default.
- Bea75171dde1a806d6551e3f85787b64e type Axiom @default.
- Bea75171dde1a806d6551e3f85787b64e annotatedProperty IAO_0000115 @default.
- Bea75171dde1a806d6551e3f85787b64e annotatedSource NCIT_C151937 @default.
- Bea75171dde1a806d6551e3f85787b64e annotatedTarget "A cancer vaccine composed of an immunogenic peptide derived from the Ras homolog family member C (RhoC; Rho-related GTP-binding protein RhoC) that is emulsified in the immunoadjuvant montanide ISA-51, with potential immunomodulating and antineoplastic activities. Upon subcutaneous administration, onilcamotide may stimulate the host immune system to mount a humoral and cytotoxic T-lymphocyte (CTL) response against tumor cells expressing RhoC, which results in tumor cell lysis. RhoC, a tumor-associated antigen (TAA) that is overexpressed in a variety of tumor cell types, is associated with increased metastatic potential." @default.